2023-505127-31-00CompletedPhase 1
A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 11 Aug 2023
- Start date
- 8 Feb 2024
- Lead sponsor
- IGM Biosciences Inc.
- Diseases
- Rheumatoid arthritis
- EU CT number
- 2023-505127-31-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 9
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (7)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nova Reuma Domyslawska I Rusilowicz Lekarza Reumatologa I Fizjoterapeuty sp.p. | Bialystok | Poland | Completed |
| Medicover Integrated Clinical Services Sp. z o.o. | Bydgoszcz | Poland | Completed |
| NZOZ Lecznica MAK MED S C | Nadarzyn | Poland | Completed |
| Medyczne Centrum Hetmańska Piotr Leszczyński | Poznan | Poland | Completed |
| Med Polonia Sp z o.o. | Poznan | Poland | Completed |
| Prywatna Praktyka Lekarska Prof. Dr HabMed Pawel Hrycaj | Poznan | Poland | Completed |
| Reumedika Sp. z o.o. | Poznan | Poland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.